Cargando…
Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: a systematic review and meta-analysis
BACKGROUND: Immunocompromised (IC) patients are at higher risk of severe SARS-CoV-2 infection, morbidity, and mortality compared to the general population. They should be prioritized for primary prevention through vaccination. This study aimed to evaluate the efficacy of COVID-19 mRNA vaccines in IC...
Autores principales: | Mehrabi Nejad, Mohammad-Mehdi, Moosaie, Fatemeh, Dehghanbanadaki, Hojat, Haji Ghadery, Abdolkarim, Shabani, Mahya, Tabary, Mohammadreza, Aryannejad, Armin, SeyedAlinaghi, SeyedAhmad, Rezaei, Nima |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840778/ https://www.ncbi.nlm.nih.gov/pubmed/35151362 http://dx.doi.org/10.1186/s40001-022-00648-5 |
Ejemplares similares
-
Seroconversion following the first, second, and third dose of SARS-CoV-2 vaccines in immunocompromised population: a systematic review and meta-analysis
por: Mehrabi Nejad, Mohammad-Mehdi, et al.
Publicado: (2022) -
Correction to: Predictors of the chest CT score in COVID‑19 patients: a cross‑sectional study
por: Yazdi, Niloofar Ayoobi, et al.
Publicado: (2021) -
Lung Involvement Found on Chest CT Scan in a Pre-Symptomatic Person with SARS-CoV-2 Infection: A Case Report
por: Asadollahi-Amin, Ali, et al.
Publicado: (2020) -
Predictors of hospital mortality among patients with COVID-19 in
Tehran, Iran
por: Esfahanian, Fatemeh, et al.
Publicado: (2021) -
Can children of the Sputnik V vaccine recipients become symptomatic?
por: Mehraeen, Esmaeil, et al.
Publicado: (2021)